TRAP1 and cancer: Recently shikonin has been shown to kill certain cancer cells and inhibit the migration and invasion of cancer cells15 through a number of possible mechanisms, including the inhibition of protein tyrosine kinase (PTK)16, the activities of DNA topoisomerases17, and tumor necrosis factor receptor-associated protein 1 (TRAP1) expression18.